Dr. Mike Nguyen

Dr. Mike Nguyen
Dr. Nguyen obtained his undergraduate education at UCSD and his medical school and urology residency training at UC Davis. He completed a fellowship in robotic and laparoscopic urologic surgery at the Cleveland Clinic. Dr. Nguyen was the director of minimally invasive urologic surgery at the University of Arizona for five years before he joined the faculty of USC in 2013. Dr. Nguyen specializes in the latest robotic and minimally invasive approaches for the treatment of kidney cancer, prostate cancer, benign prostate enlargement, and other urologic conditions. He is an expert in the surgical treatment of complex kidney stone disease with percutaneous, ureteroscopic, and shockwave procedures. Dr. Nguyen additionally offers his patients up-to-date non-surgical management for urologic diseases including effective prevention of kidney stones and active surveillance for prostate and kidney cancer in patients who are appropriate candidates. He conducts research in several areas including prostate cancer prevention, surgical technology, and the prevention of kidney stone disease. Dr. Nguyen has over 40 peer-reviewed articles in the urologic literature and is a reviewer for several urology journals.
Medical School:

University of California at Davis

Residency:

University of California at Davis

Fellowship:

Cleveland Clinic

Undergraduate:

University of California at San Diego

Locations

USC Institute of Urology Glendale, California

1808 Verdugo Blvd #318Glendale, California, 91208United States
323-865-3700 | Visit Website

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only